Qureight appoints Dr Steven Bishop as CMO
Techbio company Qureight has announced the appointment of Dr Steven Bishop as Chief Medical Officer.
Bishop previously served as Chief Data Officer for the company, which uses AI-powered CT imaging biomarkers and its clinical data management platform to advance understanding of lung and heart diseases.
As CMO, Bishop will lead Qureight’s Clinical Operations team, the team responsible for delivering customers’ global clinical studies. Having worked previously to reshape the company’s product offering, he will lead Qureight’s product development and clinical strategy.
Bishop has over 20 years of experience in healthcare and data science, including building AI solutions in both medtech and healthtech fields, and has published in the domains of critical care pathophysiology and surgical data science.
As Chief Data Officer for Qureight, he led the training of Qureight’s AI and imaging biomarker models and was also in charge of maintaining and extending Qureight’s global network of data relationships, which span NHS Trusts, hospital groups, contract research organisations and industry.
“I first joined Qureight as it was clear that the potential impact of the platform, to support clinical trials and ultimately increase treatment options for patients, was huge,” Bishop said.
Bruno Quinney, Content Team, DDW
